MediciNova, Inc. logo

MediciNova, Inc.

NASDAQ:MNOV

Overview | Financials
Company Name MediciNova, Inc.
Symbol MNOV
Currency USD
Price 2.28
Market Cap 111,825,336
Dividend Yield 0%
52-week-range 1.12 - 2.55
Industry Biotechnology
Sector Healthcare
CEO Dr. Yuichi Iwaki M.D., Ph.D.
Website https://www.medicinova.com

An error occurred while fetching data.

About MediciNova, Inc.

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple

Related Stocks

MDxHealth SA logo

MDxHealth SA

MDXH

2.375 USD

Shattuck Labs, Inc. logo

Shattuck Labs, Inc.

STTK

1.26 USD

OncoCyte Corporation logo

OncoCyte Corporation

OCX

3 USD

Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.

OLMA

11.54 USD

Poseida Therapeutics, Inc. logo

Poseida Therapeutics, Inc.

PSTX

3.69 USD

Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPR

23.87 USD

Financials

Numbers are in millions USD

Numbers are in millions USD